Free tool
FAERS Monitor: Sabril
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020427 or its brand name (Sabril, Vigabatrin). Reports on generic versions are filed under their own applications.
Reports
13,897
Serious
9,744
70% of reports
Hospitalization
4,399
Death reported
1,337
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- seizure2,541
- drug ineffective1,368
- drug dose omission990
- death842
- pneumonia521
- somnolence508
- drug withdrawal convulsions482
- off label use443
- vomiting414
- hospitalisation369
- product dose omission issue366
- epilepsy302
- condition aggravated280
- infantile spasms272
- convulsion267
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 19 |
| 2005 | 23 |
| 2006 | 28 |
| 2007 | 18 |
| 2008 | 65 |
| 2009 | 39 |
| 2010 | 275 |
| 2011 | 219 |
| 2012 | 280 |
| 2013 | 211 |
| 2014 | 1,266 |
| 2015 | 1,569 |
| 2016 | 1,483 |
| 2017 | 1,220 |
| 2018 | 959 |
| 2019 | 785 |
| 2020 | 736 |
| 2021 | 786 |
| 2022 | 887 |
| 2023 | 1,001 |
| 2024 | 910 |
| 2025 | 672 |
| 2026 | 446 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,262 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| infantile spasmsSignal | 272 | 913.1 | 786.3 | 154,025 |
| drug withdrawal convulsionsSignal | 482 | 562.2 | 507.1 | 196,513 |
| seizureSignal | 2,541 | 34.0 | 32.8 | 80,056 |
| epilepsySignal | 302 | 15.1 | 13.5 | 3,926 |
| drug dose omissionSignal | 990 | 9.1 | 8.6 | 7,155 |
| convulsionSignal | 267 | 7.1 | 6.3 | 1,389 |
| somnolenceSignal | 508 | 3.8 | 3.5 | 1,065 |
| hospitalisationSignal | 369 | 3.6 | 3.3 | 708 |
| pneumoniaSignal | 521 | 2.4 | 2.2 | 447 |
| product dose omission issue | 366 | 1.9 | 1.7 | 153 |
| drug ineffective | 1,368 | 1.6 | 1.5 | 302 |
| death | 842 | 1.5 | 1.4 | 136 |
| condition aggravated | 280 | 1.4 | 1.2 | 31 |
| vomiting | 414 | 1.3 | 1.2 | 35 |
| off label use | 443 | 0.8 | 0.7 | 33 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.